Taking action through new investment in antimicrobial resistance research
OTTAWA, May 24, 2017 /CNW/ - Theemergence of so-called "superbugs" is one of the most significant health threats to Canadians, and others around the world. Tackling Antimicrobial resistance (AMR) requires action on many fronts, including the development of new drugs to treat infections.
The Honourable Jane Philpott, Minister of Health, today announced $1.39 million from the Canadian Institutes of Health Research to support five research teams whose work will advance innovations in point-of-care diagnostics, with the goal of implementing the best diagnostic tools in health care settings and the right use of antibiotics. This funding is part of the investments the Government of Canada has made over the past year on research to address the emergence and spread of AMR. For example, Health Canada announced earlier this month several changes to the Food and Drug Regulations that will better protect Canadians against the risk of antimicrobial resistance, by better controlling access to veterinary antimicrobial drugs for food-producing animals.
The Government of Canada has also endorsed the Global Action Plan on Antimicrobial Resistance, and is currently working with our provincial and territorial partners to finalize a Pan-Canadian Framework on Antimicrobial Resistance and Antimicrobial Use in Canada. The Pan-Canadian Framework will guide collective action in tackling AMR and identify opportunities for action under four pillars: surveillance, stewardship, infection prevention and control, and research and innovation.
"Addressing AMR requires sustained efforts across multiple sectors and organizations domestically and internationally. It is only through our collective actions, including this investment in diagnostic research, that we will make real progress in mitigating the threat of AMR. The Government of Canada is committed to ongoing collaboration with our partners and to taking action to ensure that antimicrobials will continue to be an effective tool in protecting the health of Canadians."
The Honourable Jane PhilpottMinister of Health
Antimicrobial resistance in animalsFederal Action Plan on Antimicrobial Resistance and Use in Canada: Building on the Federal Framework for ActionBackgrounder – Point-of-Care Diagnostics in Human Health – Phase 1Point-of-Care funding results detailsGovernment of Canada takes action on antimicrobial resistance
SOURCE Health Canada
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All